Find a TenderAwarded

Published 24 Oct 2023, 10:12 BST

Official UK procurement notice

NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024

Official notice

Authority: NHS England (Central government)

Framework agreement4 lotsGoodsOpen procedureSME suitable

Sectors: Medical Devices & Pharma (33) Delivery: UK

Framework ceiling (notional)£1,833,333,000total for 4 lots · framework ceiling, not attributable revenue

Submissions closed 23 Nov 2023awarded 26 Jan 2024

Lots 4see the lot list below

Framework period 1 yr 6 moends 31 Aug 2025 · extension options published · starts 1 Mar 2024

What is being bought4 lots · detail below

Published requirement description

Project Title: NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024 Offer reference number: CM/PHR/22/5678 CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B. Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A. Period of framework: 1 March 2024 to 31 August 2026 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B). Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months

CPV: Pharmaceutical products

How this framework works

From the published notice

Bids received: 21 bids on the busiest of 4 lots · 38 suppliers appointed
Framework period: 1 yr 6 mo from 1 Mar 2024

Lots and requirements (4)Procurement structure

4 lots · all with a published value

Lot #1CM/PHR/22/5678/01Awarded 1 yr 6 moPublished value£377,682,000

CM/PHR/22/5678/01 - NHS Framework for North of England Branded Medicines - Tranche B. Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Contract period: 1 Mar 2024 – 31 Aug 2025 (1 yr 6 mo)

Delivery: UK · Please refer to Document No. 10 in the ITO Documents for the list of Purchasing Points

Extensions: Option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.Variant bids: allowed

33600000 Pharmaceutical products

Lot #2CM/PHR/22/5678/02Awarded 1 yr 6 moPublished value£823,674,000

NHS Framework for North of England Branded Medicines - Lot 2. (to transition to Tranche B) Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Contract period: 1 Mar 2024 – 31 Aug 2025 (1 yr 6 mo)

Delivery: UK · Please refer to Document No. 10 in the ITO Documents for the list of Purchasing Points

Extensions: Option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.Variant bids: allowed

33600000 Pharmaceutical products

Lot #3CM/PHR/22/5678/03Awarded 2 yrs 6 moPublished value£138,947,000

CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A. Period of framework: 1 March 2024 to 31 August 2026 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Contract period: 1 Mar 2024 – 31 Aug 2026 (2 yrs 6 mo)

Delivery: UK · Please refer to Document No. 10 in the ITO Documents for the list of Purchasing Points

Extensions: Option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.Variant bids: allowed

33600000 Pharmaceutical products

Lot #4CM/PHR/22/5678/04Awarded 1 yr 6 moPublished value£493,031,000

CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B). Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Contract period: 1 Mar 2024 – 31 Aug 2025 (1 yr 6 mo)

Delivery: UK · Please refer to Document No. 10 in the ITO Documents for the list of Purchasing Points

Extensions: Option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months.Variant bids: allowed

33600000 Pharmaceutical products

What it takes to win
i
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Evaluation split and conditions of participation as published; the tender pack may add more

What this means for your bid

“NHS Branded Medicines Framework for North of England and Midlands and…” is a framework: the contest is a place on its panel, not a single contract.

Procedure terms & legal framework

From the official record · publisher note attached

Procedure method: Open procedure
Legal basis: CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category: Goods
Notice status: Awarded
Procurement threshold: Unspecified in notice
Regulatory regime: Standard
Commercial structure: Framework agreement
Who may use this agreement: Not stated in the notice; call-off rights may be limited to the establishing authority
Competition type: Competitive procedure
GPA / WTO covered: Yes (GPA)
Recurring procurement: No (one-off requirement)
First published: 24 Oct 2023, 10:12 BST
Last source update: 26 Feb 2024, 12:50 GMT
Award evaluation window: 24 Nov 2023 – …
Authority reference: CM/PHR/22/5678
FTS notice number: 2024/S 000-006097
Classification (CPV): Pharmaceutical products
Delivery area: UK
Official registry OCID: ocds-h6vhtk-040e74 Find a Tender

Contract terms

Electronic trading: electronic ordering · electronic payment

Publisher note: Please note that Lot 1 was also awarded to Kent Pharma Ltd in addition to those listed under the awarded suppliers below

How it was run

Official notice

Run through: Atamis legacy domain (health-family.force.com) · Who buys & how to bid on Atamis

Supplier login requiredLanguage: EN

Access & registration note: Legacy Salesforce domain still used in notices — use the current Atamis portal · this portal address is a legacy domain; the operator has migrated

Tender documents are also served through a separate tool: https://health-family.force.com/s/Welcome ↗

Appointment period ends: 23 Nov 2023, 13:00 GMT
Submission channel: {"electronicSubmission","written"}
Accepted languages: en
Bids opened: 24 Nov 2023, 13:00 GMT

Detailed submission instructions & authority contactsFrom official release

health-family.force.com/s/Welcome ↗

Timeline

23 Nov 2023 → 1 Mar 2024 · 5 dates

Admission / appointment period endsperiod end, not a bid countdown
23 Nov 2023, 13:00 GMT
Bids opened
24 Nov 2023, 13:00 GMT
Bids must remain valid until
22 Feb 2024, 23:59 GMT
Notice published
26 Feb 2024, 12:50 GMT
Contract starts
1 Mar 2024

Notice history

2 events · 3 releases on Find a Tender · since 24 Oct 2023

Deadline moved to 23 Nov 2023, 13:00 GMT
24 Oct 2023, 11:06 BST
-1 days · was 24 Nov 2023, 13:00 GMT
Status changed to complete
26 Feb 2024, 12:50 GMT

Published amendments (1 · 1 deadline change)

When	What	Before	After	Shift
—	Contract periodII.2.7.4	1 Aug 2025	1 Aug 2026	+365 d
—	DeadlineIV.2.2.1	24 Nov 2023	23 Nov 2023	-1 d
—	Bid openingIV.2.7.1	24 Nov 2023	23 Oct 2023	-32 d
—	Bid validityIV.2.6.1	22 Feb 2024	21 Oct 2023	-124 d

1 amendment published without a description.

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast

Suppliers appointed 38admitted to the panel · see the list ↓

Bids received 215 from SMEs · busiest of 4 lots

Contracts signed 20latest 26 Jan 2024

74 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.

Contracts

All 20 of these contracts carry the same published figure, £1, the framework's maximum for the whole notice, not each contract's own value. They are not eleven separate sums.

CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B
Signed
26 Jan 2024
Value
ceiling above
Period
… – 31 Aug 2025
Status
active
CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B
Signed
26 Jan 2024
Value
ceiling above
Period
… – 31 Aug 2025
Status
active
CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B
Signed
26 Jan 2024
Value
ceiling above
Period
… – 31 Aug 2025
Status
active
CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B
Signed
26 Jan 2024
Value
ceiling above
Period
… – 31 Aug 2025
Status
active
CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B
Signed
26 Jan 2024
Value
ceiling above
Period
… – 31 Aug 2025
Status
active
CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B
Signed
26 Jan 2024
Value
ceiling above
Period
… – 31 Aug 2025
Status
active
CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B
Signed
26 Jan 2024
Value
ceiling above
Period
… – 31 Aug 2025
Status
active
CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B
Signed
26 Jan 2024
Value
ceiling above
Period
… – 31 Aug 2025
Status
active
CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B
Signed
26 Jan 2024
Value
ceiling above
Period
… – 31 Aug 2025
Status
active
CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B
Signed
26 Jan 2024
Value
ceiling above
Period
… – 31 Aug 2025
Status
active
CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B
Signed
26 Jan 2024
Value
ceiling above
Period
… – 31 Aug 2025
Status
active
CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B
Signed
26 Jan 2024
Value
ceiling above
Period
… – 31 Aug 2025
Status
active
CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B)
Signed
26 Jan 2024
Value
ceiling above
Period
… – 31 Aug 2025
Status
active
CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B)
Signed
26 Jan 2024
Value
ceiling above
Period
… – 31 Aug 2025
Status
active
CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B)
Signed
26 Jan 2024
Value
ceiling above
Period
… – 31 Aug 2025
Status
active
CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B)
Signed
26 Jan 2024
Value
ceiling above
Period
… – 31 Aug 2025
Status
active
CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B)
Signed
26 Jan 2024
Value
ceiling above
Period
… – 31 Aug 2025
Status
active
CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B)
Signed
26 Jan 2024
Value
ceiling above
Period
… – 31 Aug 2025
Status
active
CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B)
Signed
26 Jan 2024
Value
ceiling above
Period
… – 31 Aug 2025
Status
active
CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B)
Signed
26 Jan 2024
Value
ceiling above
Period
… – 31 Aug 2025
Status
active

Bid statistics published by the authority

Lot	Bids	SME	VCSE	Valid bid range
1 · CM/PHR/22/5678/01	21bids · 21 electronic · 21 from abroad	5	—	—
2 · CM/PHR/22/5678/02	21bids · 21 electronic · 21 from abroad	4	—	—
3 · CM/PHR/22/5678/03	15bids · 15 electronic · 15 from abroad	5	—	—
4 · CM/PHR/22/5678/04	20bids · 20 electronic · 20 from abroad	4	—	—

Contracting authority & participating public bodies

NHS England

Contracting authorityCentral GovernmentMinistry or any other national or federal authority, including their regional or local subdivisionsHealth Quarry House, Quarry Hill, Leeds, UK, LS2 7UEContact name, email Published organisation website ↗

Framework contractors & participating bidders

38 commercial parties on the notice

Abbvie LtdFramework contractor08004972 Abbvie House, Vanwall Business Park, Vanwall Road,, Maidenhead, Berks., UK, SL6 4UB
Accord-UK LtdFramework contractor00079585 Whiddon Valley,, Barnstaple, Devon,, UK, EX32 8NS
AlmirallFramework contractor06320852 Harman House, 1 Goerge Street,, Uxbridge,, UK, UB81QQ
Amgen LtdFramework contractor2354269 No 216 Science Park Milton Road, Cambridge, UK, CB4 0WA
AstraZenecaFramework contractor03674842 Supply Chain, 2 Pancras Square, 8th Floor,, London,, UK, N1C 4AG
Aventis Pharma ltd t/a SanofiFramework contractor01535640 410 Thames Valley, Park Drive,, Reading, Berkshire, UK, RG6 1PT
Bayer PlcFramework contractor00935048 No 400 South Oak Way, Green Park,, Reading, UK, RG2 6AD
BiogenFramework contractor01497267 Biogen Building 5 Foundation Park, Roxborough Way,, Maidenhead, Berkshire, England,, UK, SL6 3UD
CST Pharma LimitedFramework contractor04212740 Unit 5-7 Tintagel Way, Westgate Park Industrial Estate Aldridge,, Walsall,, UK, WS9 8ER
Celltrion Healthcare United Kingdom LimitedFramework contractor11685363 The Switch ,1-7 The Grove,, Slough, UK, SL1 1QP

Show 28 more suppliers

Chugai Pharma UK LtdFramework contractor2814621 Chugai Pharma UK Limited, 2nd Floor, Mulliner House, Flanders Road, Turnham Green, London, UK, W4 1NN
Dr.Reddy's Laboratories (UK) LimitedFramework contractor1729064 410, Cambridge Science Park Milton Rd, Milton,, Cambridge, UK, CB4 0PE
Eli Lilly and Company LtdFramework contractor00284385 Lilly House, Basing View,, Basingstoke, Hampshire,, UK, RG21 4FA
Galapagos Biotech LtdFramework contractor03400161 Salisbury House Station Road,, Cambridge Cambridgeshire,, UK, CB1 2LA
Gedeon Richter UK LtdFramework contractor04325685 127 Shirland Rd Maida Vale, London, UK, W9 2EP
GlaxoSmithKline UK LimitedFramework contractor04310159 980 Great West Road,, London,, UK, TW8 9GS
IpsenFramework contractor06751069 Ipsen Ltd, 190 Bath Road,, Slough,, UK, SL1 3XE
Janssen-Cilag LtdFramework contractor1027904 50-100 Holmers Farm Way,, HighWycombe,, UK, HP12 4EG
Merck Serono LimitedFramework contractor00990823 Merck Serono Limited, 5 New Square, Bedfont Lakes Business Park,, Feltham, Middlesex,, UK, TW14 8HA
Merck Sharpe and Dohme (UK) LimitedFramework contractor00233687 120 Moorgate,, London, United Kingdom, UK, EC2M 6UR
MerzFramework contractor4703428 Suite B, Breakspear Park, 39 Breakspear Way,, Hemel Hempstead,, UK, HP2 4TZ
MylanFramework contractor09189103 Building 4, Trident Place, Mosquito Way,, Hatfield, UK, AL10 9UL
Napp Pharmaceuticals LtdFramework contractor03690299 Unit 198 Cambridge Science Park, Milton Road,, Cambridge, England,, UK, CB4 0AB
Neon Healthcare LtdFramework contractor06844351 8 The Chase, John Tate Road, Foxholes Business Park, Hertford,, Hertfordshire, England,, UK, SG13 7NN
Novartis Pharmaceuticals UK LtdFramework contractor00119006 2nd Floor, The Westworks Building, White City Place, 195 Wood Lane,, London,, UK, W12 7FQ
Novo NordiskFramework contractor01118740 3 City Place, Beehive Ring Road,, Gatwick, West Sussex,, UK, RH6 0PA,
Organon Pharmaceuticals UK LtdFramework contractor00820771 The Hewett Building, 14 Hewett Street,, London, UK, EC2A 3NP
Orifarm UKFramework contractor10015046 Suite A2 Breakspear Park,, Hemel Hempstead, Hertfordshire,, UK, HP2 4TZ
Pfizer LtdFramework contractor526209 Ramsgate Road,, Sandwich, Kent,, UK, CT13 9NJ
Pharmacosmos UK LtdFramework contractor03104505 Pharmacosmos UK The White Building 33 Kings Road, Reading, Berkshire,, UK, RG1 3AR
Roche Products LtdFramework contractor00100674 Hexagon Place 6 Falcon Way, Shire Park, Welwyn Garden City, UK, AL7 1TW
Sandoz LtdFramework contractor01547204 Park View, Riverside Way, Watchmoor Park,, Camberley, Surrey., UK, GU15 3YL
Sobi (Swedish Orphan Biovitrum Ltd)Framework contractor04369760 Suite 2, Riverside 3, Granta Park,, Great Abington, Cambridgeshire., UK, CB21 6AD
Sun Pharma UK LtdFramework contractor02992795 6-9 The Square, Stockley Park,, Uxbridge, UK, UB11 1FW
Teva UK LimitedFramework contractor302461 Ridings Point, Whistler Drive,, Castleford,, UK, WF10 5HX
Thornton and Ross LtdFramework contractor185947 Linthwaite Laboratories, Manchester Road, Linthwaite,, Huddersfield, UK, HD7 5QH
Vifor Pharma UK LtdFramework contractor06514784 5 New Street Square, London, UK, EC4A 3TW
Zentiva Pharma UK LtdFramework contractor2158996 12 New Fetter Lane,, London, UK, EC4A 1JP

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.

What is being bought4 lots · detail below

How this framework works

Lots and requirements (4)Procurement structure

What it takes to winiHow this buyer will score bids.The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Procedure terms & legal framework

How it was run

Timeline

Notice history

Commercial outcome & contract awards

Contracting authority & participating public bodies

Framework contractors & participating bidders

Official documents & specifications

What it takes to win
i
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).